|
HS Code |
483287 |
As an accredited 6-Bromopurine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromopurine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Diving into the world of organic synthesis brings you face-to-face with all sorts of compounds. 6-Bromopurine stands out. Chemists run into it in plenty of research labs, whether pushing the boundaries of medicinal chemistry or piecing together intricate molecular puzzles. It’s not just a chemical formula; it’s a main ingredient in the toolkit for anyone making purine derivatives, especially those in the pharmaceutical field. Its structure—purine ring with a bromine atom lodged at the 6th position—gives it a personality of its own. That tweak changes how it behaves compared to plain purine or other purine derivatives, making it more than an idle spectator in chemical transformations.
The heart of 6-Bromopurine’s value comes from the fine details of its molecular structure. Sporting the chemical formula C5H3BrN4, this compound weighs about 199 grams per mole. The inclusion of bromine, a bulkier atom, means the compound brings unique reactivity, especially in nucleophilic substitution reactions. Its off-white to light beige crystalline appearance is hard to miss on the lab bench. It usually shows up in bottles made for shelf-stable storage and it doesn’t demand much fuss during handling—just the caution you’d give to any organic compound. The melting point tends to sit in the 185–190 degrees Celsius range, which tells you it stands up to a fair amount of heat, useful during reaction processes. Solubility becomes crucial during synthesis, and here, 6-Bromopurine dissolves reasonably in dimethyl sulfoxide or dimethylformamide, although you won’t get much action with plain water.
Where does 6-Bromopurine find its calling? Those in pharmaceutical labs appreciate its role as a building block for antimetabolic drugs, antiviral agents, and molecules dangling on the edge of cancer treatment research. The bromo group sits ready to swap out in a wide variety of chemical reactions, laying the groundwork for substitutions or further ring modifications. Medicinal chemistry teams rely on it as a stepping stone toward making purine analogs, the backbone for some of the most promising drug leads. As someone with a chemistry background, these functionalized purines remind me of the endless possibilities that open up with a clever molecular tweak. Even folks in agricultural chemistry take notice—a few purine derivatives work well as plant growth regulators, and 6-Bromopurine can step into those shoes.
Outside the life sciences, 6-Bromopurine pops up in materials science, sometimes serving as an intermediate in the creation of organic semiconductors. Not everyone dealing with electronics thinks about purine rings, but their electronic properties and ability to stack snugly into molecular structures do have appeal in advanced material applications. While I mostly dealt with drug synthesis during my graduate work, a friend’s experience in thin film research showed that the line between pharmaceuticals and materials chemistry blurs once you follow purines and their derivatives from one project to the next.
An unrushed look at 6-Bromopurine reveals why chemists value specificity. Compared to other halogenated purines—like 6-Chloropurine—the bromine atom changes the playing field. Bromine is less electronegative and larger, so its presence at the 6th position makes the molecule less reactive than the chloro version, yet more selective during certain substitutions. This can help dial down side reactions, often making syntheses cleaner or easier to purify. When making nucleoside analogs, precision matters. You don't want a beautiful synthesis to collapse under unwanted byproducts. Bromopurines carry enough reactivity to be useful, but rarely go out of control under standard conditions. That gives them an edge if you need gentler conditions or if the downstream molecules are sensitive.
It’s easy to overlook the subtle differences, but those choices influence yield, purity, and sometimes safety. Bromine leaves under milder nucleophilic attack compared to chlorine, so 6-Bromopurine unlocks substitutions that its chlorinated cousin can’t. Some pharmaceutical companies choose 6-Bromopurine specifically for these properties, preferring it over other halopurines when crafting libraries of analogs for drug discovery. In academic circles, students often learn these differences the hard way—an attempt at a substitution might fail with a 6-Chloropurine starting material, prompting a second try with the bromo version and better results.
Every compound brings its quirks to the bench. My first encounter with 6-Bromopurine stuck with me for its reliability in SNAr (nucleophilic aromatic substitution) reactions. Once you set up the glassware and measure out an aliquot, you notice it doesn't cling to the weighing paper like some more hygroscopic compounds. Its relatively high melting point means it doesn’t soften easily during TLC (thin layer chromatography) monitoring or intermediate purifications. You pour it out, add it to your solvent, and let the reaction run—knowing you won’t have unexpected headaches from decomposition or violent reactions under standard lab protocols. The handling safety differs from substances that carry isotopic or high volatility risks. While you still wear gloves and goggles like with all lab work, 6-Bromopurine doesn’t rank up there with the compounds that keep chemists awake at night.
From a storage perspective, regular chemical cabinets do the job. As long as direct sunlight and moisture stay away, the material holds up nicely over the months—sometimes years. One professor insisted on double-storing purine derivatives out of habit, but in reality, short stints on the bench before weighing, and then back into a tightly sealed container, cause no trouble. Trouble would only brew with casual spills or a lack of respect for chemical hygiene, but the same goes for just about any organic molecule sitting in a research lab.
The value of 6-Bromopurine becomes clear when you consider where modern medicines come from. Medicinal chemistry runs on the toolkit of building blocks—small, tweakable molecules that laboratories use to build complexity. Purine rings show up everywhere, from DNA and RNA to the molecular skeletons of drugs aimed at viral infections or tumor growth. Swapping a hydrogen for a bromine at the 6-position does more than just fill up a line in a catalog. It gives chemists a springboard for making analogs that can disrupt enzymes, mimic nucleosides, or slide into the genetic machinery of rapidly dividing cells. These functions matter in the search for the next breakthrough cancer treatment or a new class of antivirals. In my own research, time spent running substitutions on purine rings often led to the most promising leads of the project. The ability to handle, substitute, and push these reactions forward relies on the fundamental features that 6-Bromopurine brings to the table.
With outbreaks of new viruses and an ongoing global challenge from cancer, pharmaceutical research keeps chasing purine-like skeletons. 6-Bromopurine provides a simple, reliable foundation—one that doesn’t force a chemist to tangle with overly reactive or hazardous precursors. This steady performance underpins its popularity and the trust the science community places in it. Import numbers from chemical suppliers show that demand for this intermediate has remained stable, with modest increases as new labs spin up research into nucleic acid analogs or custom enzyme inhibitors.
Every over-the-bench compound deserves an honest look at its environmental footprint. Halogenated organics don’t always have the cleanest reputation. Long ago, disposal meant flushing everything away. We now recognize that cautious, well-managed handling keeps these molecules from slipping into the wastewater. 6-Bromopurine doesn’t carry the acute volatility of smaller halides, nor the persistence of heavy organohalogens in the environment. Still, modern labs use dedicated waste streams, marked for halogenated organic material, preventing accidental release. Laboratories direct much of their effort at minimizing waste at the source, by optimizing reaction scales and purification protocols. During my years in academic labs, waste management training never failed to include strict guidelines for 6-Bromopurine and its cousins. It’s less about fear and more about responsible stewardship—a lesson passed along between generations of chemists.
The data on actual exposure risks remains straightforward. Direct handling without gloves isn’t advised, thanks to the irritant potential of many aromatic bromides. Accidental spills rarely become emergencies unless large volumes or open flames come into play. The material safety sheets focus on keeping it sealed, away from oxidizers, and not vented in open air for long stretches. This isn’t unique to 6-Bromopurine, but a reminder that established best practices work. Some may take its non-volatile nature for granted, but regular training and secure storage keep risks low. Attention to personal protective equipment remains essential, though most researchers won’t see surprise sensitivity or significant health impacts from the quantities typically handled in organic synthesis workflows.
The only perfect compound is the one you haven’t worked with yet. 6-Bromopurine, while a reliable team player, brings some hurdles to research and industrial work. Its mediocre solubility in water can frustrate attempts at using greener solvents. Labs aiming for sustainable chemistry sometimes reconsider reactions to reduce reliance on DMSO or DMF. Substitution reactions with weaker nucleophiles seem sluggish at room temperature. Overcoming these bumps often requires balancing reaction efficiency, product yield, and cost. Colleagues have tinkered with microwaves or intensified mixing to push sluggish reactions forward without escalating side reactions or resorting to prohibitively high temperatures.
On the manufacturing side, cost can rear its head. Producing halogenated purines demands specialty reagents and tight control over reaction conditions to avoid over-halogenation. Efficient synthesis protocols minimize steps and shrink waste footprints. Multistep purifications chew up time and resources. Larger pharmaceutical firms pour money into process optimization to wring every last gram of product from their starting materials. Bench scientists often adapt their recipes, swapping solvents or scaling operations in small batches, always measuring waste and considering raw material cost. Sharing success stories, even anecdotally, helps the whole chemistry community edge toward more sustainable and economical use of key intermediates like 6-Bromopurine.
The modern market for fine chemicals sees no shortage of grades, sources, or promises. 6-Bromopurine, sold at purities tailored for research or industry, must deliver on every shipment. I’ve seen clever syntheses fall apart due to unexpected impurities in a bottle labeled “pure.” Reliable vendors test batches with robust analytical methods—HPLC, NMR, even mass spectrometry. It’s not just bureaucratic box-ticking. Reactions can change depending on an impurity just half a percent above expectations. Everything from crystal appearance to reactivity shifts as purity creeps down. I’ll never forget a project delayed three weeks because a subpar lot of 6-Bromopurine threw off the colorimetric analysis. Labs that build long-term trust with reputable suppliers enjoy smoother development cycles and more predictable results. That consistency supports peer-reviewed work, patent filings, and, most crucially, the reproducibility that makes scientific progress possible.
Another piece of the puzzle is the transparency around manufacturing. Trusted suppliers publish purity data, residual solvent content, and assure buyers about source and storage conditions. In an era when journals demand raw data and funding hinges on traceability, little details matter. A student prepping for a major synthesis wants to know if the batch comes with a certificate of analysis. Principal investigators need assurance that the compound stood up during transit, and that it was stored under precisely the right conditions. In the drive for trust, suppliers who embrace openness set themselves apart—removing the need for guesswork or repeated recrystallization to reach reliable results.
The thread tying together the successes in DNA research, antiviral drug development, and modern agriculture often runs through functionalized purines. As the world gets smarter about the interconnectedness of biology, medicine, and materials science, the demand for smartly modified molecules like 6-Bromopurine climbs higher. Academic consortia and startup labs both lean on the reliability of proven chemical intermediates to pursue innovation. The future may see greener synthetic protocols and smarter, more selective reactions using tailored catalysts or biocatalysts. The shift toward environmental stewardship and cost-aware operations could push manufacturers to explore continuous flow methods or use of alternative, less toxic reagents in production.
At its core, 6-Bromopurine embodies the steady progress of organic chemistry. It connects foundational purine research with next-generation applications, empowering researchers to tweak, test, and push boundaries. Students meet it early while learning about nucleophilic aromatic substitution; career chemists see it as an old friend, well-trusted in pursuit of the next solution to challenges in health, agriculture, or materials science. The story of 6-Bromopurine will keep moving forward, carried by those who value both its humble crystalline form and the vast, often unseen impact embedded in a modest bottle sitting on a laboratory shelf.